Abstract
Patients with hereditary thrombotic thrombocytopenic purpura (TTP), also known as the Upshaw–Schulman syndrome, have a genetic deficiency in the ADAMTS13 enzyme (1-3 Here, we report the case of a family in whom two neonates had been born with severe neonatal thrombotic microangiopathy, with death at day 3 after delivery in one infant and at day 14 after delivery in the other. Posthumous genetic analysis of the second neonate revealed pathogenic ADAMTS13 genetic variants (maternal c.1193G→A, p.Arg398His, and paternal c.3070T→G, p.Cys1024Gly) (Fig. S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org).4